Back to BlackRock, Inc. BlackRock, Inc.

ALDXALDX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ALDEYRA THERAPEUTICS INC

BlackRock, Inc. holds 1.3M shares of ALDX (ALDEYRA THERAPEUTICS INC), worth $2.7M as of 2026-Q2. The position was decreased (-66.6% shares).

Current Value

$2.7M

Current Shares

1.3M

Total Value Change

-$16.2M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.3M
-66.6%
$2.7M0.0%$2.13
0
2026-Q1
Decreased
3.8M
-2.2%
$6.4M0.0%$5.11
0
2025-Q4
Increased
3.9M
+1.2%
$19.9M0.0%$5.15
29
2025-Q3
Decreased
3.8M
-1.2%
$19.9M0.0%$5.21
0
2025-Q2
Increased
3.9M
+3.1%
$14.8M0.0%$3.79
29
2025-Q1
Decreased
3.7M
-1.4%
$21.5M0.0%$6.67
0
2024-Q4
New
3.8M
-
$18.9M0.0%$5.02
39

Other major holders of ALDX: BNP PARIBAS FINANCIAL MARKETS, Verition Fund Management LLC, VANGUARD GROUP INC, Woodline Partners LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used